SP Chattopadhyay Department of Dermatology & STD, Base Hosp. Delhi
Source of Support: None, Conflict of Interest: None
ABSTRACT: This single blinds (blind evaluator) clinical study was carried out to compare the efficacy and safety of Betamethasone dipropionate plus chinoform (Diproform) cream and Betamethasone 17-valerale plus chinoform (Betnovate-C) cream in 140 cases of clinically secondarily infected steroid-responsive dermatoses. Both cream were safe and effective, the former being better than the latter. Treatment with Diproform cream resulted in a significantly lower relapse as compared to therapy with Betnovate-C.